01 /What it is
Sigumir is a short peptide bioregulator from the Khavinson research line of tissue specific peptides. Its sequence is documented in Russian research publications focused on cartilage and joint tissue.
02 /How it works
In research models, Sigumir is studied within the bioregulator framework, which proposes tissue specific signaling from short peptides to corresponding cell populations. Its mechanism is investigated in cartilage research.
03 /What researchers explore it for
Researchers have explored Sigumir in cartilage research, in joint tissue research, and in bioregulator framework research.
04 /Safety and interactions
Sigumir is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Peptide family: Khavinson tissue specific bioregulators. Frequently compared with other bioregulators such as Cartalax, Suprefort, and Pinealon. The Apothify library lists Sigumir for encyclopedia coverage only.